PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11453472-12	2001	Enalaprilat inhibited ACE activity to < 25% of baseline activity without changing cardiorespiratory or blood gas values, compared with horses administered saline solution.	Enalaprilat	0-11	angiotensin I converting enzyme	Equus caballus	22-25	
11453472-13	2001	CONCLUSIONS AND CLINICAL RELEVANCE: Enalaprilat administration almost completely inhibited ACE activity in horses without changing the hemodynamic responses to intense exercise and is unlikely to be of value in preventing exercise-induced pulmonary hemorrhage.	Enalaprilat	36-47	angiotensin I converting enzyme	Equus caballus	91-94	
9118114-2	1989	In vitro, equine serum ACE was sensitive to the following inhibitors (IC50): enalapril (570 nM or 215 ng/ml), captopril (190 nM or 41.3 ng/ml), and enalaprilat (6 nM or 2.1 ng/ml).	Enalaprilat	148-159	angiotensin I converting enzyme	Equus caballus	23-26